Farmak
63 Kyrylivska Street, Kyiv, Kyiv City, 04080, Ukraine
Overview
Farmak is a Ukraine-based pharmaceutical company that creates and manufactures medical drugs. Since 2010, Farmak is the leader of the pharmaceutical market of Ukraine and the largest exporter of medicines. The company has 20 production lines that meet GMP requirements. Since 2015, JSC "Farmak" has its own complex for the manufacture of substances (Department of Production of API) in Shostka, the planned capacity of which is 100 tons of substances per year.
- Total investments
- 3
- Lead investments
- 1
- Investments · 12mo
- 1
- Active investors
- 1
Sector focus
- Health Care
- Manufacturing
- Medical
- Pharmaceutical
Investment portfolio
- Tayra AI
Led · Equity · Jul 2026
Tayra AI is an AI startup based in Vinnytsia that develops tools to ease administrative work for doctors. The company announced a disclosed investment on July 21 and, per Farmak's project manager Sergey Brizhitsky, is currently valued at about $3 million. As part of the recent financing, Tayra AI sold a 7% stake to Farmak in a $200,000 transaction that also involved two unnamed business angels from Farmak's leadership. The articles do not provide revenue, user, or other operating metrics, nor do they detail prior funding rounds or specific plans for the new capital. No founding year or further operational details were reported in the coverage.
- Altris.AI
Participated · Equity · Dec 2022
Altris AI develops an AI platform that assists eye care professionals in detecting more than 100 pathologies, including age-related macular degeneration, glaucoma, and choroidal nevus. The company offers a medical image management platform and a free educational mobile app for clinicians. Its platform is already installed in more than 30 clinics, and its mobile app is used by over 11,000 ophthalmologists and optometrists. Altris AI partners with global OCT distributors and equipment manufacturers such as Topcon Healthcare, Optopol, and Huvitz. The company plans to use newly raised funds to scale its AI-enabled eye care diagnostics solution. Altris AI is headquartered in the USA with R&D centers in Kyiv, Ukraine and Malaga, Spain, and is led by founder and CEO Andrey Kuropyatnyk.
- ComeBack Mobility
Participated · Seed · Jul 2021
ComeBack Mobility builds smart sensors that attach to crutches to support rehabilitation following diseases and injuries of the lower extremities. The product is designed to provide assistive technology during physical recovery and to improve outcomes for patients using crutches. The team is based in Dnipro and was one of nine projects that pitched at the Ukrainian Startup Fund’s 32nd Pitch Day. As part of that pitch, ComeBack Mobility was selected for seed‑stage support and awarded a $50,000 grant. The company’s current disclosed financing comes from this grant; no revenue, user, or prior‑round metrics were provided in the article. The article does not specify detailed future product roadmaps or commercialization timelines. ComeBack Mobility develops "Smart Crutch Tip" orthopedic devices that pair with a smartphone app shared between patients and doctors. The technology enables electronic communication and provides an overview of a patient’s walking recovery progress, including monitoring how the patient loads the injured leg. Patients receive rehabilitation programs set by their doctors through the app, which helps them stay consistent with exercises and adhere to prescribed load limits. Medical professionals access a web and/or mobile app containing data on all their patients, allowing remote monitoring, addressing concerns, and adapting programs as needed. The company is led by CEO Ilya Popov and operates out of Ukraine with additional offices in Jackson, WY. In August 2021 it raised $1M in seed funding.
Team
Volodymyr Kostiuk
CEO
LinkedIn